Table 1.
| Result, % | |
| Lesion morphology | |
| EP | 76.4 |
| PM | 40.54 |
| Both EP and PM | 16.21 |
| Erosion | 10.8 |
| Swelling | 16.21 |
| Distribution | |
| Hands | 8.1 |
| Feet | 95.94 |
| Both | 4.05 |
| Laterality | |
| Unilateral | 31.08 |
| Bilateral | 68.91 |
| Symmetry | |
| Symmetrical | 51.35 |
| Asymmetrical | 44.59 |
| Unknown | 4.05 |
| Symptoms | |
| Pruritus | 32.4 |
| Pain | 27 |
| Asymptomatic | 48.6 |
| Extracutaneous manifestations | |
| Frequency | 29.6 |
| Type | |
| Respiratory | 50 |
| General | 50 |
| Latency period, days | 16.15 |
| COVID‐19 symptoms | |
| Symptoms present | |
| Cough | 52.38 |
| Fever | 33.33 |
| Asthenia/myalgia | 28.57 |
| Diarrhoea/nausea/vomiting | 19 |
| Dyspnoea | 9.52 |
| Anosmia/ageusia | 4.76 |
EP, erythematous papules; PM, purpuric macules.